Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
Non-caspase-mediated apoptosis contributes to the potent cytotoxicity of the enediyne antibiotic lidamycin toward human tumor cells
Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27Kip and p21Cip
Pharmacogenetics of human 3′-phosphoadenosine 5′-phosphosulfate synthetase 1 (PAPSS1): gene resequencing, sequence variation, and functional genomics
Selection of insulin-producing rat insulinoma (RINm) cells with improved resistance to oxidative stress
Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targeting
An amperometric biosensor with human CYP3A4 as a novel drug screening tool
Large-conductance K+ channel openers NS1619 and NS004 as inhibitors of mitochondrial function in glioma cells
K-ATP channel independent effects of pinacidil on ATP production in isolated cardiomyocyte or pancreatic β-cell mitochondria
Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities
Preclinical factors affecting the interindividual variability in the clearance of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid
Monoamine oxidase A inhibitory potency and flavin perturbation are influenced by different aspects of pirlindole inhibitor structure
Cytosolic β-glycosidases for activation of glycoside prodrugs of daunorubicin
Inhibition of leptin release by atrial natriuretic peptide (ANP) in human adipocytes
In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors
Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats
Intracellular signal transduction modulating expression of plasminogen activator inhibitor-1 in adipocytes
Erratum to “Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2” [Biochem. Pharmacol. 65 (2003) 813-821],